Skip to content
Brand Protocol

Stomach Acidity and Heartburn

Protocols Brand Protocols AOR
Stomach Acidity and Heartburn

This protocol was developed for practitioners using Fullscript in Canada and the templates cannot be applied to accounts operating outside of Canada.

Disclaimer

The Fullscript Integrative Medical Advisory team has developed or collected these protocols from practitioners and supplier partners to help health care practitioners make decisions when building treatment plans. By adding this protocol to your Fullscript template library, you understand and accept that the recommendations in the protocol are for initial guidance and may not be appropriate for every patient.

Upload this template

Stomach Acidity and Heartburn

Total Protocol Duration: 8 weeks

Gastro Relief

2 capsules, 2 times daily for 1 month (2 bottles) before food, week 1 to 4.

Description: Anti-microbial mastic gum. Sodium alginate reduces reflux. Zn carnosine is synergistic with triple ABX therapy, heals ulcers.

Pro Andrographis

2 capsules, 2 times daily, week 2 to 6.

Description: Anti-inflammatory and immunostimulant. In vitro studies show anti-urease activity to prevent H. pylori colonization.

Pro GI Repair

1 scoop, 2 to 3 times daily before food, week 1 to 8. Mix in 250mL of liquid on an empty stomach.

Description: Anti-inflammatory and promotes the healing of GI lining. Glycyrrhiza polysaccharides are mucoprotective and are shown to have anti-adhesive effects of H. pylori. Zn carnosine is synergistic with triple ABX therapy, heals ulcers.

Optional: Quercetin or Pro Quercetin

1 capsule, 2 times daily with food, week 1 to 4.

Description: Reduces free radicals involved in peptic ulcer formation, inhibits H. pylori colonization, reduces gastric inflammation and apoptosis.

 

The following may be considered according to requirements for additional support:

  • The combo of the zinc carnosine in both the Gastro Relief and Pro GI Repair formulations provides the evidence bases minimum dose of 75 mg two times daily for H. pylori therapy.
  • Clinicians should consider suggestion dietary lecithin granules, due to their phosphatidylcholine content, which have a protective effect on the gastric cells.
  • High degree of relapse; may require multiple rounds of treatment. The above protocol is safe and complementary with triple ABX therapy.
  • GERD is a common symptom of SIBO since epigastric bloating increases intraluminal pressure. Consider in differential and treatment (See dysbiosis protocol).

 

 

AOR Professional not available in retail health-food stores or online to the general public

Fullscript content philosophy

At Fullscript, we are committed to curating accurate, and reliable educational content for practitioners and patients alike. Our educational offerings cover a broad range of topics related to integrative medicine, such as supplement ingredients, diet, lifestyle, and health conditions.

Medically reviewed by expert practitioners and our internal Integrative Medical Advisory team, all Fullscript content adheres to the following guidelines:

  1. In order to provide unbiased and transparent education, information is based on a research review and obtained from trustworthy sources, such as peer-reviewed articles and government websites. All medical statements are linked to the original reference and all sources of information are disclosed within the article.
  2. Information about supplements is always based on ingredients. No specific products are mentioned or promoted within educational content.
  3. A strict policy against plagiarism is maintained; all our content is unique, curated by our team of writers and editors at Fullscript. Attribution to individual writers and editors is clearly stated in each article.
  4. Resources for patients are intended to be educational and do not replace the relationship between health practitioners and patients. In all content, we clearly recommend that readers refer back to their healthcare practitioners for all health-related questions.
  5. All content is updated on a regular basis to account for new research and industry trends, and the last update date is listed at the top of every article.
  6. Potential conflicts of interest are clearly disclosed.